Conditions

close

result 5995 件

FullText URL K0006687_abstract_review.pdf K0006687_fulltext.pdf K0006687_summary.pdf
Author HAN, YANYAN|
Published Date 2022-09-22
Content Type Thesis or Dissertation
Grant Number 甲第6687号
Granted Date 2022-09-22
Thesis Type Doctor of Philosophy in Medical Science
Grantor 岡山大学
language English
Copyright Holders © 2020 by The Japanese Society for Lymphoreticular Tissue Research
FullText URL K0006686_abstract_review.pdf K0006686_fulltext.pdf K0006686_summary.pdf
Author TOKUMASU, Miho|
Published Date 2022-09-22
Content Type Thesis or Dissertation
Grant Number 甲第6686号
Granted Date 2022-09-22
Thesis Type Doctor of Philosophy in Medical Science
Grantor 岡山大学
language English
Copyright Holders © 2022, Oxford University Press
JaLCDOI 10.18926/AMO/64044
FullText URL 76_5_609.pdf
Author Matsumoto, Ken| Fujishita, Keigo| Matsuda, Masayuki| Oka, Satoshi| Fujisawa, Yuka| Imai, Toshi| Machida, Takuya|
Abstract A 69-year-old Japanese man with acute leukemia received post-transplant cyclophosphamide-based haploidentical stem cell transplantation (PTCY-haplo-SCT) but was readmitted with dyspnea and ground-glass-opacities of the lungs. Bronchoscopy showed inflammatory changes with no signs of infection. He received steroids but required intubation as his condition deteriorated. In addition to antithymocyte globulin and cyclophosphamide, we administered ruxolitinib but failed to save him. Autopsy findings revealed fibrotic nonspecific interstitial pneumonia (NSIP) without evidence of organizing pneumonia or infection. Thus, we diagnosed idiopathic pneumonia syndrome (IPS). As far as our knowledge, this is the first case of IPS with NSIP histology after PTCY-haplo-SCT.
Keywords idiopathic pneumonia syndrome ruxolitinib post-transplant cyclophosphamide-based haploidentical stem cell transplantation nonspecific interstitial pneumonia
Amo Type Case Report
Publication Title Acta Medica Okayama
Published Date 2022-10
Volume volume76
Issue issue5
Publisher Okayama University Medical School
Start Page 609
End Page 615
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2022 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 36352810
Web of Science KeyUT 000884907100016
JaLCDOI 10.18926/AMO/64040
FullText URL 76_5_585.pdf
Author Choshi, Haruki| Watanabe, Mototsugu| Furukawa, Shinichi| Ujike, Hiroyuki| Kataoka, Kazuhiko|
Abstract Pulmonary metastatic resection is a standard therapy for renal cell carcinoma (RCC). Although patients with pulmonary metastases who do not undergo any treatment have poor prognoses, it has been reported that resection for pulmonary metastases yields good clinical outcomes. We investigated the prognoses of the 10 Japanese patients (eight males, two females) who underwent a surgical resection of pulmonary metastasectomy from RCC at our institution between April 1, 2012 and March 31, 2020 and analyzed the prognostic factors. We determined the prognoses and calculated the 5-year overall survival (OS) and disease-free survival (DFS) rates. To identify prognostic factors, we compared the median DFS duration for each factor. Elderly patients (median age, 75.5 years) were more predominant compared to previous studies, and all 10 patients underwent a complete resection. The 5-year DFS rate was 30.5% (95%CI: 0.045-0.63) and the 5-year OS rate was 80% (95%CI: 0.20-0.97). The following factors were associated with better prognosis: female, disease-free interval≥36 months, and metastases size<12 mm. These results indicate that complete resection for pulmonary metastases from RCC resulted in good clinical outcomes, particularly for patients with better prognostic factors.
Keywords renal cell carcinoma pulmonary metastasis complete resection
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2022-10
Volume volume76
Issue issue5
Publisher Okayama University Medical School
Start Page 585
End Page 591
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2022 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 36352806
Web of Science KeyUT 000884907100012
JaLCDOI 10.18926/AMO/64036
FullText URL 76_5_547.pdf
Author Kagawa, Hidetoshi| Yamanaka, Ryutaro| Hiromasa, Tsutomu|
Abstract This observational study aimed to clarify the long-term results of the combination of mizoribine (MZB), tacrolimus (TAC) and prednisolone as first-line therapy for lupus nephritis (LN). This was our institution’s standard therapy between 2009 and 2015, when we saw 36 patients with LN. When a patient thus treated achieved SLEDAI remission (= 0) and/or the prednisolone dose could be tapered to 5 mg/day, either MZB or TAC was stopped, and the other was continued for maintenance therapy. If treatment failure or relapse occurred, second-line therapy was introduced. At years 1 and 5, overall complete renal response and SLEDAI remission were 94% and 88%, and 50% and 62%, respectively. Excluding 2 cases lost to follow-up, medications after 5 years were as follows: 20 (59%) were stable on 1 drug (MZB or TAC), 11 (32%) required continuation of both drugs (MZB + TAC), and 3 (9%) required second-line therapy. The 5-year retention rate was 91% (non-secondline), with 0% of relapse in this group. Our first-line combination strategy showed high remission rates in the induction phase, and subsequent maintenance therapy demonstrated good outcomes for up to 5 years. Research that fine-tunes the order of therapeutic agents and institutes appropriate treatment goals may further improve long-term outcomes for patients with LN.
Keywords combination therapy first-line therapy lupus nephritis mizoribine tacrolimus
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2022-10
Volume volume76
Issue issue5
Publisher Okayama University Medical School
Start Page 547
End Page 555
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2022 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 36352802
Web of Science KeyUT 000884907100008
JaLCDOI 10.18926/AMO/64033
FullText URL 76_5_527.pdf
Author Makihara, Seiichiro| Kariya, Shin| Miyamoto, Shotaro| Uraguchi, Kensuke| Oka, Aiko| Tsumura, Munechika| Noda, Yohei| Ando, Mizuo| Okano, Mitsuhiro|
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2022-10
Volume volume76
Issue issue5
Publisher Okayama University Medical School
Start Page 527
End Page 533
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2022 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 36352799
Web of Science KeyUT 000884907100005
JaLCDOI 10.18926/AMO/64025
FullText URL 76_5_503.pdf
Author Ogawa, Hirohito| Honda, Tomoyuki|
Abstract Eukaryotic genomes contain numerous copies of endogenous viral elements (EVEs), most of which are considered endogenous retrovirus (ERV) sequences. Over the past decade, non-retroviral endogenous viral elements (nrEVEs) derived from ancient RNA viruses have been discovered. Several functions have been proposed for these elements, including antiviral defense. This review summarizes the current understanding of nrEVEs derived from RNA viruses, particularly endogenous bornavirus-like elements (EBLs) and endogenous filovirus-like elements (EFLs). EBLs are one of the most extensively studied nrEVEs. The EBL derived from bornavirus nucleoprotein (EBLN) is thought to function as a non-coding RNA or protein that regulates host gene expression or inhibits virus propagation. Ebolavirus and marburgvirus, which are filoviruses, induce severe hemorrhagic fever in humans and nonhuman primates. Although the ecology of filoviruses remains unclear, bats are believed to be potential reservoirs. Based on the knowledge from EBLs, it is postulated that EFLs in the bat genome help to maintain the balance between filovirus infection and the bat’s defense system, which may partially explain why bats act as potential reservoirs. Further research into the functions of nrEVEs could reveal novel antiviral systems and inspire novel antiviral approaches.
Keywords EVE nrEVE bornavirus filovirus antiviral
Amo Type Review
Publication Title Acta Medica Okayama
Published Date 2022-10
Volume volume76
Issue issue5
Publisher Okayama University Medical School
Start Page 503
End Page 510
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2022 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 36352796
Web of Science KeyUT 000884907100002
JaLCDOI 10.18926/AMO/64024
FullText URL 76_5_489.pdf
Author Matsumoto, Yuji| Ichikawa, Tomotsugu| Kurozumi, Kazuhiko| Date, Isao|
Abstract Glioblastoma (GBM) is a fatal primary malignant brain tumor in adults. Despite decades of research, the prognosis for GBM patients is still disappointing. One major reason for the intense therapeutic resistance of GBM is inter- and intra-tumor heterogeneity. GBM-intrinsic transcriptional profiling has suggested the presence of at least three subtypes of GBM: the proneural, classic, and mesenchymal subtypes. The mesenchymal subtype is the most aggressive, and patients with the mesenchymal subtype of primary and recurrent tumors tend to have a worse prognosis compared with patients with the other subtypes. Furthermore, GBM can shift from other subtypes to the mesenchymal subtype over the course of disease progression or recurrence. This phenotypic transition is driven by diverse tumor-intrinsic molecular mechanisms or microenvironmental factors. Thus, better understanding of the plastic nature of mesenchymal transition in GBM is pivotal to developing new therapeutic strategies. In this review, we provide a comprehensive overview of the current understanding of the elements involved in the mesenchymal transition of GBM and discuss future perspectives.
Keywords glioma glioblastoma mesenchymal subtype mesenchymal transition heterogeneity
Amo Type Review
Publication Title Acta Medica Okayama
Published Date 2022-10
Volume volume76
Issue issue5
Publisher Okayama University Medical School
Start Page 489
End Page 502
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2022 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 36352795
Web of Science KeyUT 000884907100001
FullText URL fulltext.pdf
Author Yamada, Hiroshi| Abe, Tadashi| Nagaoka, Hikaru| Takashima, Eizo| Nitta, Ryo| Yamamoto, Masahiro| Takei, Kohji|
Keywords IFN-inducible GTPase Irgb6 GTPase membrane T gondii
Published Date 2022-09-09
Publication Title Frontiers In Cellular And Infection Microbiology
Volume volume12
Publisher Frontiers Media
Start Page 992198
ISSN 2235-2988
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 Yamada, Abe, Nagaoka, Takashima, Nitta, Yamamoto and Takei.
File Version publisher
PubMed ID 36159643
DOI 10.3389/fcimb.2022.992198
Web of Science KeyUT 000873786000001
Related Url isVersionOf https://doi.org/10.3389/fcimb.2022.992198
FullText URL fulltext.pdf
Author Kataoka, Motoki| Misawa, Masaaki| Tsuruta, Kenji|
Keywords phononic crystal topological acoustic elastic waveguide backscattering length lamb wave
Published Date 2022-10-13
Publication Title Symmetry
Volume volume14
Issue issue10
Publisher MDPI
Start Page 2133
ISSN 2073-8994
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 by the authors.
File Version publisher
DOI 10.3390/sym14102133
Web of Science KeyUT 000873707300001
Related Url isVersionOf https://doi.org/10.3390/sym14102133
FullText URL fulltext.pdf
Author Araki, Hiroyuki| Tazawa, Hiroshi| Kanaya, Nobuhiko| Kajiwara, Yoshinori| Yamada, Motohiko| Hashimoto, Masashi| Kikuchi, Satoru| Kuroda, Shinji| Yoshida, Ryuichi| Umeda, Yuzo| Urata, Yasuo| Kagawa, Shunsuke| Fujiwara, Toshiyoshi|
Published Date 2022-12-15
Publication Title Molecular Therapy - Oncolytics
Volume volume27
Publisher Cell Press
Start Page 3
End Page 13
ISSN 2372-7705
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 The Author(s).
File Version publisher
PubMed ID 36212775
DOI 10.1016/j.omto.2022.09.003
Web of Science KeyUT 000870232500001
Related Url isVersionOf https://doi.org/10.1016/j.omto.2022.09.003
FullText URL fulltext.pdf
Author Gao, Shangze| Liu, Keyue| Ku, Wenhan| Wang, Dengli| Wake, Hidenori| Qiao, Handong| Teshigawara, Kiyoshi| Nishibori, Masahiro|
Keywords Histamine HMGB1 vascular endothelial cell H-1 receptor hypotension
Published Date 2022-10-05
Publication Title Frontiers In Immunology
Volume volume13
Publisher Frontiers Media SA.
Start Page 930683
ISSN 1664-3224
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 Gao, Liu, Ku, Wang, Wake, Qiao, Teshigawara and Nishibori.
File Version publisher
PubMed ID 36275732
DOI 10.3389/fimmu.2022.930683
Web of Science KeyUT 000873745300001
Related Url isVersionOf https://doi.org/10.3389/fimmu.2022.930683
FullText URL fulltext.pdf
Author Fithroni, Abdul Basith| Kobayashi, Kazuko| Uji, Hirotaka| Ishimoto, Manabu| Akehi, Masaru| Ohtsuki, Takashi| Matsuura, Eiji|
Keywords boron neutron capture therapy (BNCT) biologically self-degradable amphipathic polymer (Lactosome) hydrophobic boron cluster carborane isomers or o-carborane alkylated derivatives molecular glue effect
Published Date 2022-10-21
Publication Title CELLS
Volume volume11
Issue issue20
Publisher MDPI
Start Page 3307
ISSN 2073-4409
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 by the authors.
File Version publisher
PubMed ID 36291173
DOI 10.3390/cells11203307
Web of Science KeyUT 000872497500001
Related Url isVersionOf https://doi.org/10.3390/cells11203307
FullText URL fulltext.pdf
Author Shigehiro, Tsukasa| Ueno, Maho| Kijihira, Mayumi| Takahashi, Ryotaro| Umemura, Chiho| Taha, Eman A.| Kurosaka, Chisaki| Asayama, Megumi| Murakami, Hiroshi| Satoh, Ayano| Nakamura, Yoshimasa| Futami, Junichiro| Masuda, Junko|
Keywords breast cancer cells dendritic cells mesenteric lymph node myeloid-derived suppressor cells
Published Date 2022-09-20
Publication Title International Journal Of Molecular Sciences
Volume volume23
Issue issue19
Publisher MDPI
Start Page 11035
ISSN 1422-0067
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 by the authors.
File Version publisher
PubMed ID 36232335
DOI 10.3390/ijms231911035
Web of Science KeyUT 000867767200001
Related Url isVersionOf https://doi.org/10.3390/ijms231911035
FullText URL fulltext20230112-5.pdf
Author Matsuo, Toshihiko| Tanaka, Takehiro| Omote, Rika| Okada, Toshiaki| Notohara, Kenji| Okada, Kazuya|
Published Date 2022
Publication Title Journal of Clinical and Experimental Hematopathology
Volume volume62
Issue issue4
Publisher Japanese Society for Lymphoreticular Tissue Research
Start Page 226
End Page 237
ISSN 1346-4280
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 The Japanese Society for Lymphoreticular Tissue Research
File Version publisher
PubMed ID 36171112
DOI 10.3960/jslrt.22015
Related Url isVersionOf https://doi.org/10.3960/jslrt.22015
FullText URL fulltext.pdf
Author Tokumitsu, Hiroshi| Sakagami, Hiroyuki|
Keywords CaMKK CaM-kinase cascade Ca2+ signaling phosphorylation
Published Date 2022-09-20
Publication Title INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume volume23
Issue issue19
Publisher MDPI
Start Page 11025
ISSN 1422-0067
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 by the authors.
File Version publisher
PubMed ID 36232320
DOI 10.3390/ijms231911025
Web of Science KeyUT 000867778400001
Related Url isVersionOf https://doi.org/10.3390/ijms231911025
FullText URL fulltext.pdf
Author Wang, Dengli| Ousaka, Daiki| Qiao, Handong| Wang, Ziyi| Zhao, Kun| Gao, Shangze| Liu, Keyue| Teshigawara, Kiyoshi| Takada, Kenzo| Nishibori, Masahiro|
Keywords intracerebral hemorrhage HMGB1 antibody therapy non-human primate
Published Date 2022-09-23
Publication Title Cells
Volume volume11
Issue issue19
Publisher MDPI
Start Page 2970
ISSN 2073-4409
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 by the authors.
File Version publisher
PubMed ID 36230933
DOI 10.3390/cells11192970
Web of Science KeyUT 000866922400001
Related Url isVersionOf https://doi.org/10.3390/cells11192970
FullText URL fulltext.pdf
Author Makimoto, Go| Shimonishi, Atsushi| Ohashi, Kadoaki| Ninomiya, Kiichiro| Higo, Hisao| Kato, Yuka| Fujii, Masanori| Kubo, Toshio| Ichihara, Eiki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki|
Keywords MET Tepotinib Non-small-cell lung cancer
Published Date 2022
Publication Title Case Reports In Oncology
Volume volume15
Issue issue2
Publisher Karger
Start Page 494
End Page 498
ISSN 1662-6575
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 The Author(s).
File Version publisher
PubMed ID 35702678
DOI 10.1159/000524326
Web of Science KeyUT 000864085100005
Related Url isVersionOf https://doi.org/10.1159/000524326
FullText URL fulltext.pdf
Author Kondo, Yuki| Rikiishi, Kazuhide| Sugimoto, Manabu|
Keywords 8-oxo-dGTP nudix hydrolase Oryza sativa transcriptional error UV-C
Published Date 2022-09
Publication Title Antioxidants
Volume volume11
Issue issue9
Publisher MDPI
Start Page 1805
ISSN 2076-3921
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 by the authors.
File Version publisher
PubMed ID 36139879
DOI 10.3390/antiox11091805
Web of Science KeyUT 000858199700001
Related Url isVersionOf https://doi.org/10.3390/antiox11091805
FullText URL fulltext.pdf
Author Naka, Shuhei| Matsuoka, Daiki| Goto, Kana| Misaki, Taro| Nagasawa, Yasuyuki| Ito, Seigo| Nomura, Ryota| Nakano, Kazuhiko| Matsumoto-Nakano, Michiyo|
Keywords Streptococcus mutans collagen-binding protein membrane permeability cell structure RNA-seq
Published Date 2022-09-13
Publication Title Frontiers In Cellular And Infection Microbiology
Volume volume12
Publisher Frontiers Media S.A.
Start Page 994014
ISSN 2235-2988
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 Naka, Matsuoka, Goto, Misaki, Nagasawa, Ito, Nomura, Nakano and Matsumoto-Nakano.
File Version publisher
PubMed ID 36176579
DOI 10.3389/fcimb.2022.994014
Web of Science KeyUT 000861324100001
Related Url isVersionOf https://doi.org/10.3389/fcimb.2022.994014